RxDoctor Payments Data

Jill Tanner

Physician Assistant · Los Angeles, CANPI 1528434313

Payments from drug & device makers

$4,797in general payments, 2019–2025

Across 205 payments — averaging $23.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$529
  • Novartis$502
  • Esperion Therapeutics, Inc.$443
  • Abbott$418
  • Boston Scientific$406
  • Amgen$382
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$4,777100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,797 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban113$91,329
Repatha SureclickEvolocumab64$68,259
JardianceEmpagliflozin35$38,930
OzempicSemaglutide22$25,284
XareltoRivaroxaban16$23,196
MounjaroTirzepatide16$20,010
FarxigaDapagliflozin Propanediol19$17,814
BrilintaTicagrelor12$11,231
PaxlovidNirmatrelvir/Ritonavir37$5,594
Telmisartan93$2,887
Rosuvastatin Calcium129$2,130
Atorvastatin Calcium185$2,073
Metoprolol Succinate154$2,034
Ezetimibe50$1,295
Famotidine71$1,249

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$212$96,923150 claims
Boehringer IngelheimJardiance$123$38,93035 claims
AstraZenecaFarxiga, Brilinta$141$29,04531 claims
Novo NordiskOzempic$340$25,28422 claims
Johnson & JohnsonXarelto$211$23,19616 claims
Lilly USA, LLCMounjaro$66$20,01016 claims
AbbVieSynthroid$184$84417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →